Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator-Induced Diaphragm Dysfunction in Rats.

Clinical and Translational Science
Stephanie E HallScott K Powers

Abstract

Mechanical ventilation (MV) is a life-saving intervention for many critically ill patients. Unfortunately, prolonged MV results in the rapid development of inspiratory muscle weakness due to diaphragmatic atrophy and contractile dysfunction (termed ventilator-induced diaphragm dysfunction (VIDD)). Although VIDD is a major risk factor for problems in weaning patients from MV, a standard therapy to prevent VIDD does not exist. However, emerging evidence suggests that pharmacological blockade of angiotensin II type 1 receptors (AT1Rs) protects against VIDD. Nonetheless, the essential characteristics of AT1R blockers (ARBs) required to protect against VIDD remain unclear. To determine the traits of ARBs that are vital for protection against VIDD, we compared the efficacy of two clinically relevant ARBs, irbesartan and olmesartan; these ARBs differ in molecular structure and effects on AT1Rs. Specifically, olmesartan blocks both angiotensin II (AngII) binding and mechanical activation of AT1Rs, whereas irbesartan prevents only AngII binding to AT1Rs. Using a well-established preclinical model of prolonged MV, we tested the hypothesis that compared with irbesartan, olmesartan provides greater protection against VIDD. Our results reve...Continue Reading

References

Nov 15, 2000·Biochemical Pharmacology·P M VanderheydenG Vauquelin
Dec 22, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·A M BoriekM B Reid
Apr 19, 2002·Journal of Applied Physiology·Scott K PowersStephen L Dodd
Jan 24, 2004·American Journal of Respiratory and Critical Care Medicine·Theodoros Vassilakopoulos, Basil J Petrof
Aug 11, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Li YaoAkira Nishiyama
Mar 29, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Aladin M BoriekJoseph R Rodarte
Oct 13, 2005·Journal of Cardiovascular Pharmacology·David E MireMichael K Pugsley
Mar 24, 2007·American Journal of Respiratory and Critical Care Medicine·Karen MaesGhislaine Gayan-Ramirez
Mar 28, 2008·The New England Journal of Medicine·Sanford LevineJoseph B Shrager
Mar 6, 2010·Journal of Applied Physiology·Melissa A WhiddenScott K Powers
Oct 12, 2010·Lancet·Neill K J AdhikariGordon D Rubenfeld
Nov 15, 2011·Journal of Applied Physiology·Ashley J SmuderScott K Powers
Jul 12, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Scott K PowersAshley J Smuder
Mar 13, 2015·Medicinal Research Reviews·Claudio Cabello-VerrugioFelipe Simon
Sep 12, 2015·Journal of Applied Physiology·Oh Sung KwonScott K Powers
Sep 15, 2016·American Journal of Respiratory and Critical Care Medicine·Gaëtan BéduneauUNKNOWN WIND (Weaning according to a New Definition) Study Group and the REVA (Réseau Européen de Recherche en Ventilation Artificie
Jun 27, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Takanobu TakezakoKoichi Node
Jul 13, 2018·Exercise and Sport Sciences Reviews·Scott K PowersMatthew J Hinkley
Jan 20, 2019·Intensive Care Medicine Experimental·Vanessa ZambelliGiacomo Bellani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.